NKCC2 (Slc12a1 in Supplementary Fig. 1) was also downregulated on a gene expression level, whereas immunohistochemistry showed overexpression of NKCC2 in the HD group (Fig. 5). The gene discussed is SLC12A1; the disease is Huntington disease.